Stay updated on Efficacy Safety of Sintilimab IBI310 in EBV Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Efficacy Safety of Sintilimab IBI310 in EBV Gastric Cancer Clinical Trial page.

Latest updates to the Efficacy Safety of Sintilimab IBI310 in EBV Gastric Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedA new record revision (v3.6.3) is added to the history and a prior revision (v3.6.2) is removed, updating the version history and provenance of the record.SummaryDifference0.1%

- Check22 days agoChange DetectedA newer revision entry, v3.6.2, was added to the study record history, replacing the previous v3.6.0. This signals an update to the record version.SummaryDifference0.1%

- Check37 days agoChange DetectedThe study record history was updated to include the responsible party (Shen Lin) and a last-verified marker, and the revision was advanced to v3.6.0, replacing the previous status block and version.SummaryDifference3%

- Check44 days agoChange DetectedThe history shows a new revision label, updating from v3.5.4 to v3.5.5. This appears to be an internal update to the record page rather than new study information.SummaryDifference0.1%

- Check65 days agoChange DetectedA new revision entry 'Revision: v3.5.4' was added to the record history, replacing the earlier 'Revision: v3.5.3'. This indicates a new version of the page has been published in the history.SummaryDifference0.1%

- Check86 days agoChange DetectedThis update reflects a minor website/app revision change for ClinicalTrials.gov (version number increment), with no new or removed information in the trial’s record history table.SummaryDifference0.1%

Stay in the know with updates to Efficacy Safety of Sintilimab IBI310 in EBV Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy Safety of Sintilimab IBI310 in EBV Gastric Cancer Clinical Trial page.